Xiao Yan-Yu, Liu Fang, Chen Zhi-Peng, Ping Qi-Neng
Department ofPharmaceutics, China Pharmaceutical University, Nanjing 210009, China.
Yao Xue Xue Bao. 2010 Nov;45(11):1440-6.
This study is to prepare the microemulsion-based gel based on the W/O microemulsion and fluorouracil (5-Fu) as a model drug to study the transdermal characterization and observe its skin irritation of the microemulsion-based gel in vitro. IPM acted as oil phase, AOT as surfactant, Tween 85 as cosurfactant, water was added dropwise to the oil phase to prepare W/O microemulsion at room temperature using magnetic stirring, then 5-Fu powder was added. The gelatin was used as substrate to prepare 5-Fu microemulsion-based gel. The permeation flux of 5-Fu from 5-Fu microemulsion-based gel across excised mice skin was determined in vitro using Franz diffusion cell to study the influence of the amount of gelatin and the drug loading capacity. Refer to 5-Fu cream, the irritation of microemulsion and microemulsion-based gel on the rat skin was studied. Based on the water/AOT/Tween 85/IPM microemulsion, only the gelatin can form the microemulsion-based gel. At 25 degrees C, 32 degrees C and 40 degrees C, the amount of gelatin required for the formation of microemulsion-based gel were 7%, 14% and more than 17%, respectively. The 12 h transdermal cumulated permeation amount of 5-Fu from microemulsion-based gel containing 14% gelatin and 0.5% drug loading were (876.5 +/- 29.1) microg x cm(-2), 12.3 folds and 4.5 folds more than 0.5% 5-Fu aqueous solution and 2.5% (w/w) 5-Fu cream, respectively. Microemulsion-based gel exhibited some irritation, but could be subsided after drug withdrawal. Microemulsion-based gel may be a promising vehicle for transdermal delivery of 5-Fu and other hydrophilic drug.
本研究旨在制备以W/O微乳和氟尿嘧啶(5-Fu)为模型药物的微乳凝胶,以研究其体外透皮特性并观察微乳凝胶对皮肤的刺激性。以IPM为油相,AOT为表面活性剂,吐温85为助表面活性剂,在室温下通过磁力搅拌将水逐滴加入油相中制备W/O微乳,然后加入5-Fu粉末。以明胶为基质制备5-Fu微乳凝胶。采用Franz扩散池体外测定5-Fu从5-Fu微乳凝胶透过离体小鼠皮肤的渗透通量,研究明胶用量和载药量的影响。参照5-Fu乳膏,研究微乳和微乳凝胶对大鼠皮肤的刺激性。基于水/AOT/吐温85/IPM微乳,只有明胶能形成微乳凝胶。在25℃、32℃和40℃下,形成微乳凝胶所需的明胶量分别为7%、14%和超过17%。含14%明胶和0.5%载药量的微乳凝胶中5-Fu的12 h透皮累积渗透量分别为(876.5±29.1)μg·cm-2,分别是0.5% 5-Fu水溶液和2.5%(w/w)5-Fu乳膏的12.3倍和4.5倍。微乳凝胶表现出一定的刺激性,但停药后可消退。微乳凝胶可能是5-Fu和其他亲水性药物经皮给药的一种有前景的载体。